Page results
-
The first ever treatment for the rare neurodegenerative disease Friedreich’s ataxia – for which UCLH and UCL led the UK trial – has been approved for use in the UK by the medicines’ regulator.
-
We’re delighted to announce that our Grafton Way Elective Surgical Hub has been successfully accredited as an elective surgical hub delivering high standards in clinical and operational practice.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
Nailesh Rambhai became an associate non-executive director at UCLH in April 2022. A lawyer by background, he has also acted as group counsel and company secretary to a number of firms including the Coventry Building Society and Petronas.
-
A new research project spearheaded by the CCTU at UCLH is trying to make more places on clinical trials available to young cancer patients aged between 16 and 24 years.
-
“Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.
-
The stroke team at the National Hospital for Neurology and Neurosurgery (NHNN) is the first in the NHS to carry out implants on cryptogenic stroke patients rather than refer them to a cardiology service.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
File results
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0363 - External management/ business consultants spend/ fees to recruitment agencies for 2023
-
FOI/2023/0356 - Current wait time for referral to treatment with a consultant for osteoporosis
-
FOI/2023/0361 - List of all the doctors and consultants working within UCLH
-
FOI/2023/0353 - Junior doctors remuneration for days on strike/will be on strike
-
FOI/2023/0368 - Apprenticeship Levy - 2019-20 to 2022/23 (Part 1)